ArticleSexually transmitted diseases2026
Strategies to Support HIV Pre-Exposure Prophylaxis Implementation: A National Programmatic Experience in Sexually Transmitted Infection Clinics.
Article in Sexually transmitted diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPre-exposure prophylaxis (PrEP) is a highly effective human immunodeficiency virus (HIV) prevention method. Expanding access to PrEP is essential to strengthening HIV prevention efforts and supporting national HIV prevention goals. National efforts to improve PrEP services in sexually transmitted infection (STI) specialty clinics were assessed by measuring changes in clinic capacity and patient outcomes and identifying key implementation strategies.
methodsQuantitative and qualitative data were collected on activities from January 1, 2021, through December 31, 2023, as part of two programs led by the Centers for Disease Control and Prevention. One program supported 26 health department STI clinics in 15 states and the District of Columbia; the other supported the National Network of STD Clinical Prevention Training Centers (NNPTC). Using a mixed-methods evaluation approach, quantitative data included clinic capacity assessments and aggregate visit-level patient outcome measures; qualitative reports were thematically analyzed for PrEP implementation strategies and NNPTC support activities.
resultsClinics reported increases in PrEP prescriptions and in capacity to provide PrEP services. Five key implementation strategies supporting in-house PrEP provision were identified: navigation services with referral networks, multimedia marketing campaigns, same-day PrEP initiation, long-acting injectable PrEP, and patient-centered education materials. NNPTC supported clinics by offering training, technical assistance, and other resources to address implementation barriers.
conclusionSTI clinics are a key venue for PrEP delivery. National efforts to expand PrEP services in this setting were supported by tailored implementation strategies and partnership with NNPTC. The findings highlight opportunities to further improve PrEP access and strengthen HIV prevention services nationally.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.